Probiotics Slow Brain Aging by Protecting Telomeres and Boosting Mitochondria

Cognitive decline associated with aging remains one of medicine's most urgent unsolved challenges, driven in large part by DNA damage and deteriorating mitochondrial function in neurons. Identifying safe, accessible interventions that target these root mechanisms could be transformative for healthy aging.

This study tested three well-known probiotic strains — Lactobacillus delbrueckii (LD), Streptococcus thermophilus (ST), and Bifidobacterium longum (LB) — individually and in combinations in SAMP8 mice, a genetically engineered model of accelerated aging. Starting at four months old, mice received probiotics for 24 weeks while researchers tracked cognitive performance, brain pathology, telomere length, and mitochondrial health.

All probiotic groups showed meaningful improvements. Neuronal damage was reduced and synaptic plasticity enhanced, translating into measurable gains in memory and cognitive function. Crucially, telomere attrition — a hallmark of cellular aging — was slowed, and mitochondrial function was restored, addressing two fundamental drivers of brain aging simultaneously. Gut microbiota analysis revealed increased abundance of beneficial genera like Limosilactobacillus and Ligilactobacillus, along with favorable metabolite shifts including elevated piperidine-4-carboxamide and Leu-Ile-Glu-Glu, and reduced Paramuribaculum.

Probiotic combinations consistently outperformed single strains, pointing to synergistic mechanisms likely involving both direct microbiome remodeling and downstream gut-brain axis signaling that protects neuronal integrity.

While these findings are promising, the study is limited to an accelerated-aging mouse model, and translation to humans requires clinical validation. The specific mechanisms linking gut metabolite changes to telomere and mitochondrial protection also warrant deeper investigation.